Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
•
Male Breast Cancer
Is it reasonable to use hypofractionation in early stage male breast cancer s/p lumpectomy?
What clinical and pathologic features - if any - would necessitate conventional fractionation?
Answer from: Radiation Oncologist at Community Practice
Absolutely the same as what we do for women with breast cancer.
Comments
Radiation Oncologist at Allegheny Health Network, Pittsburgh
Agreed, while we don't have an RCT for male breast...
Radiation Oncologist at SSM Cancer Center/St Louis CyberKnife
Taking this question further, can we assume that p...
6090
15916
Sign In
or
Register
to read more
12580
Related Questions
How do you approach the discussion about the potential risks of radiation therapy exposure and the development of secondary malignancies for patients with germline BRCA1/2 mutations?
How would you manage a pT2N1a invasive ductal carcinoma s/p lumpectomy and sentinel lymph node biopsy with ECE, and two mildly avid axillary lymph nodes on post-op PET/CT?
How do you approach reirradiation in a patient who underwent breast-conserving surgery for recurrent breast cancer after initial lumpectomy and APBI?
Is re-excision of residual disease ever itself an indication for PMRT?
What volumes and dose would you use for a chest wall recurrence in a patient who had previous mastectomy and completed only a partial prior course of PMRT?
Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?
Would you offer partial breast irradiation for a patient who otherwise meets PBI guidelines but has a PTEN mutation?
What are your top takeaways in Medical Oncology from SABCS 2025?
How, if at all, does your practice differ between male and female breast cancer patients with respect to the use of bolus?
Would you forgo lumpectomy cavity boost for grade 1 papillary carcinoma with associated grade 1 DCIS that has been resected with good margins?
Agreed, while we don't have an RCT for male breast...
Taking this question further, can we assume that p...